title: Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
abstract: Mifepristone (RU-486) has recently been granted approval from the Food and Drug Administration for the early termination of pregnancy. Availability is anticipated during 1997. This article describes the pharmacologic function of mifepristone and discusses its potential clinical use in the United States, including its safety, efficacy, and possible complications.
authors.affiliation: University of Michigan, Ann Arbor, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Mackenzie
authors.forename: S
authors.initials: S
authors.lastname: Yeo
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000191:economics / Q000494:pharmacology; D000028:Abortion, Induced / Q000379:methods* / Q000451:nursing; D016527:Drug Costs; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000191:economics / Q000494:pharmacology; D009721:Nurse Midwives; D011247:Pregnancy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone